Shared insight on the respective roles of PSMA-PET imaging and PSA doubling time in the current prostate cancer treatment paradigm.
Evan Y. Yu, MD, Fred Hutchinson Cancer Research Center
Advertisement
Articles by Evan Y. Yu, MD, Fred Hutchinson Cancer Research Center
Broad discussion on the evolution of care in prostate cancer from both the therapeutic and imaging standpoints.
Advertisement
Latest Updated Articles
Optimizing Use of PSMA PET Imaging and PSADT in Prostate CancerPublished: March 30th 2022 | Updated:
Overview of Improvements in Prostate Cancer ManagementPublished: March 30th 2022 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Lurbinectedin-Based Triplet Shows Clinical Benefit in Advanced Soft Tissue Sarcoma
2
Ultra-Sensitive ctDNA and CSF Liquid Biopsy May Refine Monitoring and Adaptive Trial Designs in Metastatic Breast Cancer
3
Anti–Gremlin-1 Therapy Plus Chemo Makes Waves in GI Malignancies
4
Nuvisertib Yields Strong Safety, Promising Efficacy in R/R Myelofibrosis
5